{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-165651","form_type":"8-K","ticker":"STOK","cik":"0001623526","company_name":"Stoke Therapeutics, Inc.","filed_at":"2024-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.295879+00:00","generated_at":"2026-06-01T02:51:48.349647+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Stoke Therapeutics COO steps down; Huw Nash remains as Chief Business Officer","bullets":["Huw Nash, Ph.D., stepped down as COO effective June 18, 2024, by mutual agreement with the company.","Nash continues in his role as Chief Business Officer, retaining business development responsibilities.","No successor Chief Operating Officer was named; the COO position appears eliminated or duties reassigned."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-165651","json":"https://secwatch.observer/filing/0001193125-24-165651.json","markdown":"https://secwatch.observer/filing/0001193125-24-165651.md","text":"https://secwatch.observer/filing/0001193125-24-165651.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1623526/000119312524165651/0001193125-24-165651-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1623526/000119312524165651/d856457d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T02:51:48.349647+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3a42981b5f","claim":"Huw Nash changed role as Chief Operating Officer at Stoke Therapeutics, Inc..","evidence_excerpt":"On June 18, 2024, Stoke Therapeutics, Inc. (the “Company”) and Huw Nash, Ph.D., the Company’s Chief Operating Officer and Chief Business Officer, announced that they have mutually agreed that Dr. Nash would step down from his position as Chief Operating Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1623526/000119312524165651/0001193125-24-165651-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}